Cergentis is part of Solvias

  • We’ve brought our Targeted Locus Amplification (TLA) technology platform and expertise in genetic characterization and QC to Solvias to support development of safe and effective advanced therapies. Solvias is a global CMC analytical services leader with a 25-year track record of serving pharma and biotech innovators worldwide.
  • We are proud to remain your familiar and trusted scientific partner for genetic characterization and QC services. You can still expect the same data security, high-quality reporting, and personal customer service you have always received.
  • With Solvias, you have a single, trusted partner with deep CMC testing expertise supporting your entire drug development journey—from initial investigation to commercialization. Together with Solvias, we remain deeply committed to providing you with scientific expertise and highly personalized service.